CDLX
Income statement / Annual
Last year (2023), Cardlytics, Inc.'s total revenue was $309.20 M,
an increase of 3.57% from the previous year.
In 2023, Cardlytics, Inc.'s net income was -$134.70 M.
See Cardlytics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$309.20 M |
$298.54 M |
$267.12 M |
$186.89 M |
$210.43 M |
$150.68 M |
$130.37 M |
$112.82 M |
$77.63 M |
| Cost of Revenue |
$178.83 M
|
$185.91 M
|
$163.78 M
|
$123.62 M
|
$130.97 M
|
$96.00 M
|
$80.26 M
|
$72.41 M
|
$52.49 M
|
| Gross Profit |
$130.38 M
|
$112.63 M
|
$103.34 M
|
$63.27 M
|
$79.46 M
|
$54.68 M
|
$50.11 M
|
$40.41 M
|
$25.14 M
|
| Gross Profit Ratio |
0.42
|
0.38
|
0.39
|
0.34
|
0.38
|
0.36
|
0.38
|
0.36
|
0.32
|
| Research and Development Expenses |
$51.35 M
|
$54.44 M
|
$38.10 M
|
$17.53 M
|
$11.70 M
|
$16.21 M
|
$12.15 M
|
$13.90 M
|
$11.60 M
|
| General & Administrative Expenses |
$58.81 M
|
$81.45 M
|
$66.22 M
|
$46.53 M
|
$36.72 M
|
$34.23 M
|
$20.10 M
|
$21.36 M
|
$18.20 M
|
| Selling & Marketing Expenses |
$57.43 M
|
$74.75 M
|
$66.00 M
|
$45.31 M
|
$43.83 M
|
$41.88 M
|
$31.93 M
|
$31.26 M
|
$32.78 M
|
| Selling, General & Administrative Expenses |
$116.24 M
|
$156.19 M
|
$132.22 M
|
$91.84 M
|
$80.55 M
|
$76.11 M
|
$52.03 M
|
$52.62 M
|
$50.98 M
|
| Other Expenses |
$98.46 M
|
$37.54 M
|
$29.87 M
|
$7.83 M
|
$4.54 M
|
-$2.10 M
|
$6.28 M
|
-$13.26 M
|
-$432,000.00
|
| Operating Expenses |
$266.05 M
|
$248.17 M
|
$200.19 M
|
$117.20 M
|
$96.78 M
|
$95.60 M
|
$67.21 M
|
$70.74 M
|
$64.78 M
|
| Cost And Expenses |
$444.87 M
|
$434.08 M
|
$363.97 M
|
$240.82 M
|
$227.76 M
|
$191.60 M
|
$147.46 M
|
$143.15 M
|
$117.27 M
|
| Interest Income |
$3.85 M
|
$1.44 M
|
$297,000.00
|
$440,000.00
|
$829,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.18 M
|
$2.56 M
|
$12.56 M
|
$3.05 M
|
$1.38 M
|
$3.26 M
|
$8.24 M
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$29.52 M
|
$43.74 M
|
$33.66 M
|
$12.42 M
|
$7.40 M
|
$3.28 M
|
$3.03 M
|
$4.22 M
|
$2.19 M
|
| EBITDA |
-$99.00 M |
-$418.98 M |
-$89.91 M |
-$39.51 M |
-$12.79 M |
-$45.97 M |
-$8.37 M |
-$24.00 M |
-$37.45 M |
| EBITDA Ratio |
-0.32
|
-0.31
|
-0.23
|
-0.23
|
-0.06
|
-0.2
|
-0.1
|
-0
|
-0.49
|
| Operating Income Ratio |
-0.44
|
-0.45
|
-0.36
|
-0.29
|
-0.08
|
-0.27
|
-0.13
|
-0.5
|
-0.51
|
| Total Other Income/Expenses Net |
$968,000.00
|
-$8.93 M
|
-$13.83 M
|
-$1.50 M
|
$181,000.00
|
-$12.13 M
|
-$2.54 M
|
-$19.46 M
|
-$1.00 M
|
| Income Before Tax |
-$134.70 M
|
-$466.71 M
|
-$136.43 M
|
-$55.42 M
|
-$17.14 M
|
-$53.04 M
|
-$19.64 M
|
-$75.70 M
|
-$40.64 M
|
| Income Before Tax Ratio |
-0.44
|
-1.56
|
-0.51
|
-0.3
|
-0.08
|
-0.35
|
-0.15
|
-0.67
|
-0.52
|
| Income Tax Expense |
$0.00
|
-$1.45 M
|
-$7.86 M
|
$3.05 M
|
$548,000.00
|
-$12.13 M
|
$5.74 M
|
$32.11 M
|
-$16,000.00
|
| Net Income |
-$134.70 M
|
-$465.26 M
|
-$128.57 M
|
-$58.47 M
|
-$17.69 M
|
-$53.04 M
|
-$19.64 M
|
-$75.70 M
|
-$40.63 M
|
| Net Income Ratio |
-0.44
|
-1.56
|
-0.48
|
-0.31
|
-0.08
|
-0.35
|
-0.15
|
-0.67
|
-0.52
|
| EPS |
-3.69 |
-13.92 |
-3.99 |
-2.15 |
-0.75 |
-2.78 |
-1.01 |
-5.4 |
-2.9 |
| EPS Diluted |
-3.69 |
-13.92 |
-3.99 |
-2.15 |
-0.75 |
-2.78 |
-1.01 |
-5.4 |
-2.9 |
| Weighted Average Shares Out |
$36.49 M
|
$33.42 M
|
$32.20 M
|
$27.21 M
|
$23.75 M
|
$19.06 M
|
$19.52 M
|
$14.03 M
|
$14.03 M
|
| Weighted Average Shares Out Diluted |
$36.49 M
|
$33.42 M
|
$32.20 M
|
$27.21 M
|
$23.75 M
|
$19.06 M
|
$19.52 M
|
$14.03 M
|
$14.03 M
|
| Link |
|
|
|
|
|
|
|
|
|
